Prelude Therapeutics Statistics
NASDAQ: PRLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.23-0.025 (-0.77%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Prelude Therapeutics by the numbers
Prelude Therapeutics has a market capitalization of $258.6 million based on 65.34M shares outstanding. With trailing EPS of $-0.59, Prelude Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.6% below its 50-day average and 21.8% below its 200-day average.
Average daily trading volume is 432.74K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PRLD valuation vs. peer median
| Metric | PRLD | Peer median | Difference |
|---|---|---|---|
| Market cap | $258.63M | $259.23M | -0% |
| Avg. volume | 432.74K | 553.65K | -22% |
Peer median across 8 companies: EBS, ALT, VCRE, GALT, QTTB, TTRX, LFCR, RLMD.
Valuation
- Market cap
- $258.63M
- Price / sales (latest FY)
- 21.30
- EPS (TTM)
- $-0.59
- Shares outstanding
- 65.34M
Price and trading
- Previous close
- 3.26
- Open
- 3.21
- Day range
- 3.17 – 3.30
- 52-week range
- 1.30 – 6.83
- 52-week change
- +93.41%
- Beta
- —
- Volume
- 299.25K
- Average volume
- 432.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 258.63M
- Forward Pe
- -7.08
- Eps
- -0.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.83
- Week52 Low
- 1.30
- Avg Volume
- 432.74K
- Shares Outstanding
- 65.34M
- Ma50
- 3.83
- Ma200
- 4.13
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -52.71%
- Pct From52w Low
- 149.42%